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Available online 4 January 2017Background: Real-life data on the role of emergency medical services (EMS) in acute heart failure (AHF) are
scarce. Our aim was to describe prehospital treatment of AHF and to compare patients using EMS with self-
presented, non-EMS patients.
Methods: Data were collected retrospectively from three university hospitals in Helsinki metropolitan area be-
tween July 1, 2012 and July 31, 2013. According to the use of EMS, patients were divided into EMS and non-
EMS groups.
Results: The study included 873 AHF patients. One hundred were (11.5%) EMS and 773 (88.5%) non-EMS. EMS
patients more often had comorbidities. Initial heart rate (HR) and peripheral oxygen saturation (SpO2) differed
between EMS and non-EMS patients; mean HR 89.2 (SD 22.5) vs. 83.7 (21.5)/min (p = 0.02) and SpO2 90.3
(8.6) vs. 92.9 (6.6)% (p = 0.01). However, on presentation to ED EMS patients' vital signs were similar to non-
EMS patients'. On presentation to ED 46.0% were normotensive and 68.2% “warm andwet”. Thirty-four percent-
age of EMS patients received prehospital medication. In-hospital mortality was 6.0% and 7.1% (p = 0.84) and
length of stay (LOS) 7.7 (7.0) and 8.5 (7.9) days (p = 0.36) in EMS and non-EMS groups.
Conclusion: The use of EMS and administration of prehospital medication was low. EMS patients had initially
worse HR and SpO2 than non-EMS patients. However, EMS patients' signs improved andwere similar on presen-
tation to ED. There were no differences in in-hospital mortality and LOS. This underscores the need for equal at-
tention to any AHF patient independent of the arrival mode.





Acute heart failure (AHF) is one of the most common reasons for
hospital admission among elderly people. However, only a minority of
these patients uses emergency medical services (EMS) [1].
The role of early treatment of AHF, including prehospital care, has
been emphasized noticeably in the recently published 2016 ESC Guide-
lines for the diagnosis and treatment of acute and chronic heart failure
(HF) aswell as in the recommendations on prehospital and early hospi-
tal management of AHF [2,3]. However, there is a significant lack of
knowledge on the actual characteristics of prehospital management of
AHF and on the differences between patients arriving by ambulance
and those self-presenting into emergency department (ED). The litera-
ture on prehospital AHF treatment mainly focuses on the treatment of
severe AHF conditions such as non-invasive ventilation (NIV) in acute
pulmonary oedema, the second most common manifestation of AHFiversity of Helsinki, Division of
dicine and Services, Helsinki
a).
.
[4–6]. The data on the effectiveness and safety of prehospital medica-
tions is scarce.
The aim of this study was first to describe the implementation and
effects of EMS in AHF patients. Second we wanted to compare the clin-
ical characteristics of patients arriving to the ED by ambulance to those
self-presenting as well as their length of hospital stay (LOS) and in-
hospital mortality.2. Material and methods
In this retrospective multicentre study, we included all patients admitted to the ED
with a primary discharge diagnosis of congestive HF. Data were collected from three uni-
versity hospitals in the Helsinki metropolitan area between July 1, 2012 and July 31, 2013.
Patients transferred to the ED from another hospital were excluded. According to the use
of EMS, patients were divided into EMS and self-presenting, non-EMS groups.
Prehospital and hospital data were collected from the regional clinical information
system. The prehospital data were collected from the Merlot Medi electronic patient
reporting system (CGI, Finland) and the in-hospital data from the Uranus electronic pa-
tient information system (CGI, Finland). The data included patient history, prehospital
and in-hospital management, the first prehospital vital signs (heart rate (HR), systolic
blood pressure (SBP), peripheral oxygen saturation (SpO2), and respiratory rate (RR)),
vital signs on presentation to ED, and LOS and in-hospital mortality. These variables
were compared between the non-EMS and EMS group.
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systemic or pulmonary venous congestion and/or hypoperfusion. In addition, chest x-ray
was evaluated for congestion, interstitial or alveolar pulmonary oedema, and pleural effu-
sion. According to thesefindings patientswere classified into four different clinical profiles
(warm andwet, warm and dry, cold andwet, and cold and dry) [7]. Results from themost
recently done echocardiogram were also evaluated. The patients were divided into three
groups according to their left ventricular ejection fraction (LVEF) (EF b 40%, reduced EF;
EF 40–49%, mid-range EF and EF ≥ 50%, preserved EF).
All patients were categorized into four groups according to their SBP on presen-
tation to ED: Group 1 (SBP b 100 mm Hg), group 2 (SBP 100–119 mm Hg), group 3
(SBP 120–160 mm Hg), and group 4 (SBP N 160 mm Hg).
The emergency-dispatching centre assessed the urgency and complaints of EMS pa-
tients. According to local EMS guidelines the urgency is categorized as A, B, C, or D according
to the recommended response time from call to EMS arrival on site. In categories A and B the
upper limit of the response time is 8min, in categoryC30min and in categoryD120min. The
level of EMSunit alsodiffers in these four categories. In categoryA, thepatient is taken careby
the highest advanced life support (ALS) unit available. ALS units contain continuous positive
airway pressure (CPAP) equipment, intravenousmorphine, nitrate infusion and intravenous
beta-blocker (metoprolol) among other advanced treatments. In categories B, C, and D, the
basic life support (BLS) unit first assesses the patient and evaluates the possible need for a
more advancedunit and/or physician on site. BLS units are equippedwith supplementary ox-
ygen, crystalloid infusion, nitrate spray, and acetylsalicylic acid, aswell as defibrillator and in-
tubation equipment. The BLS units do not contain any intravenous medication or CPAP
equipment. If needed a physician staffed mobile intensive care unit (MICU) is sent on site.
Due to the small number of patients in category A and the equal response timewith category
B, these two categories were combined for statistical analyses.
For study purposes, themain complaints recorded by the dispatching centrewere cat-
egorized into five major groups: a) dyspnoea, b) general weakness, c) chest pain,
d) transportation from nursing home or primary health care, and e) other complaints.
Four time points (call to the dispatching centre, EMS arrival on site, departure from
the site, and patient presentation to the ED) were collected from the EMS database, and
corresponding time intervals were analysed.
Mortality difference between EMS and non-EMS patients was further analysed with
propensity score matching [8]. Nearest neighbour 1:1 matching with a caliper width 0.2
of the standard deviation (SD) of thepropensity scorewithout replacementwas used. Pro-
pensity score was estimated with included potential confounders of mortality: age, gen-
der, medical history (chronic heart failure (CHF), coronary artery disease, previous
history of acutemyocardial infarction, previous history of coronary artery bypass graft sur-
gery, hypertension, diabetes, cerebrovascular disease, chronic kidney disease, and chronic
obstructive pulmonary disease), and initial presentation (SBP, HR, and SpO2). Initial RR
(datamissing in 25%) was included in the propensity score estimation in a separate sensi-
tivity analysiswith all the variables above. Balance betweenmatched groupswas assessed
with standardized mean differences (SMD).
The categorical variables are presented in numbers (n) and percentages (%), and con-
tinuous variables inmeanswith the SD. Time is presented as themean andSD inhours and
minutes (hh:mm). The threshold p-value for statistical significance was 0.05. Statistical
analyses were performed using SPSS 22.0 statistical software (IBM Corp., Armonk, NY,
USA). The study had the institutional approval of Helsinki University Hospital.3. Results
Our study included 873 patients: 100 (11.5%) in the EMS group and
773 (88.5%) in the non-EMS group. The patient characteristics are pre-
sented in Table 1. The mean age of all patients was 75.7 (11.7) years
[9,10]. The proportions of females and those with a history of diabetes
were slightly but not significantly higher in the EMS group compared
to the non-EMS group. However, a significantly greater proportion of
EMS patients had a previous history of CHF (p= 0.048), acute myocar-
dial infarction (p = 0.042), coronary artery disease (p = 0.012), and
chronic kidney disease (p b 0.001). The mean LVEF of all patients was
46.3% (SD 16.0). In total 26.3% of patient had reduced LVEF and 34.2%
of patients had preserved LVEF. The majority of patients had mid-
range LVEF. The LVEF did not differ between EMS and non-EMS patients
(p = 0.525) (Table 1.).
The major complaints were dyspnoea (n = 38, 38.0%) and general
weakness (n = 27, 27.0%), followed by chest pain (n = 9, 9.0%).
Twenty-six (26.0%) patients had other complaints or were trans-
portations to the ED from a nursing home or primary health care unit.
Regarding urgency categories, three (3.0%) patients were in urgency
category A, 30 (30.0%) in category B, 46 (46.0%) in category C, and 20
(20.0%) in category D. BLS units took care of 57% of all EMS patients,
and ALS units took care of 39%. A MICU took care of 4% of all patients.
Eighty-four percentages of all dispatched EMS units were on site
within the recommended response time. The mean response time was0:19 (0:18) (Table 2). The recommended response timeswere achieved
in 97.7%of cases in category C, and in all cases in categoryD.However, in
categories A and B, only 54.8% of cases reached the recommended re-
sponse time.
The prehospital and ED presentation vital signs aswell as SBP classes
are presented in Table 3. Thirty-three percentages of EMS patients had
prehospital SpO2 on room air b90%. Fifty percentages of these patients
were taken care byALS units. Clinically and statistically themain finding
was a decrease in the patients' mean HR from 89.2 beats per minute
(bpm) on site to 84.5 bpm on presentation to the ED (p = 0.024).
The chest x-ray findings of all patients were as follows: 61.9% had
pulmonary congestion, 12.8% interstitial pulmonary oedema, 3.6% alve-
olar pulmonary oedema, and 47.2% had pleural effusion. Jugular venous
pressure was elevated in 12.8% of patients, and peripheral oedemas
were reported in 47.4%. According to the clinical criteria 68.2% of AHF
patients were profiled as warm and wet, 13.9% warm and dry, another
13.9% as cold and wet, and 2.5% as cold and dry. The profile of cold
and dry wasmore common in the EMS group (p=0.009). No statistical
differences were observed in the three other clinical profiles.
Prehospital medication was administered to 34% of EMS patients.
Fifty percentage of de novo and 28.4% of CHF patients received
prehospital medication. The administered prehospital treatments in-
cluded intravenousmorphine, intravenousmetoprolol, nitrate spray, ni-
trate infusion, and a combination of inhaled ipratropium bromide and
salbutamol. Twenty-one (21.0%) patients received intravenous mor-
phine. A similar proportion received nitrate spray. Of these 21 patients,
11 suffered from chest pain and 17 were hypertensive (SBP N
140mmHg). Metoprolol was given to nine (9.0%) patients, nitrate infu-
sion to seven (7.0%), and a combination of ipratropium bromide and
salbutamol to another seven (7.0%). Intravenous morphine was admin-
istered in a mean cumulative dose of 4.7 (2.2) mg and metoprolol 2.3
(1.3) mg. The maximum rate of nitrate infusion was 1.1 (0.2) mg/h.
None of the patients received prehospital CPAP treatment.
Mean LOS of the total study population was 8.4 (7.8) days, with no
significant difference observed between EMS (7.7 (7.0) days) and
non-EMS patients (8.5 (7.9) days) (p = 0.363). Likewise, the in-
hospital mortalities were similar, being 6.0% in the EMS group and
7.1% in the non-EMS group (p= 0.836). In addition, in-hospital mortal-
ity between the two groups was assessed with propensity score
matching. Thematching procedure resulted in 87matched pairs; no sig-
nificant imbalances between the groups remained with respect to pro-
pensity score (SMD 0.006), the covariates used (SMD b0.12 for all) or
the average of absolute values of SMDs of covariates (0.056). After pro-
pensity score matching, the result remained similar in the two groups:
6.9% in EMS vs. 8.0% in non-EMS (p=0.8). Sensitivity analysis including
initial RR in the propensity score estimation showed a similar result.
4. Discussion
This study described the current practices in the prehospital AHF
management. Secondly, it illustrated the characteristics of EMS and
non-EMS patients. Our first finding was that a rather small proportion
of AHF patients used ambulance. These patients more often had a histo-
ry of CHF, coronary artery disease, acute myocardial infarction, and
chronic kidney disease. Secondly, we discovered that few patients re-
ceived medication in EMS. Third, EMS patients were initially more un-
stable but their vital signs improved before presentation to ED.
However, the prevalence of dry and cold patients was significantly
higher in the EMS group. Lastly, the LOS and in-hospital mortality
were similar in EMS and non-EMS groups.
Our first finding, that only one-tenth of AHF patients used EMS is
somewhat surprising. Similarly, a previous study showed that AHF pa-
tients weremore likely to self-present to the ED [1]. Patients presenting
with worsening CHF more often arrived by ambulance to the ED than
thosewith de novo AHF. The proper use of EMS among de novo patients
may be limited due to difficulties in recognizing the alarming symptoms
Table 1
Patient characteristics, n (%).
All, n = 873 (100.0) EMS patients, n = 100 (11.5) Non-EMS patients, n = 773 (88.5) P-value
Age, mean (SD) 75.7 (11.7) 76.2 (10.8) 75.6 (11.9) 0.621
Female 423 (48.5) 55 (55.0) 368 (47.6) 0.169
Medical history
Chronic heart failure 568 (65.1) 74 (74.0) 494 (63.9) 0.048
Coronary artery disease 335 (38.4) 50 (50.0) 285 (36.9) 0.012
Previous myocardial infarction 138 (15.8) 23 (23.0) 115 (14.9) 0.042
CABG 134 (15.3) 23 (23.0) 111 (14.4) 0.038
Hypertension 556 (63.8) 60 (68.0) 488 (63.2) 0.378
Diabetes mellitus 374 (42.8) 50 (50.0) 324 (41.9) 0.133
Chronic atrial fibrillation 384 (44.0) 47 (47.0) 337 (43.6) 0.523
Cerebrovascular disease 125 (14.3) 13 (13.0) 112 (14.5) 0.763
Significant valvular disease 55 (6.3) 10 (10.3) 51 (6.7) 0.208
Chronic kidney disease 170 (19.5) 38 (38.0) 132 (17.1) b0.001
History of DCMP 90 (10.3) 10 (10.0) 80 (10.3) 1.000
COPD 136 (15.6) 20 (20.0) 116 (15.0) 0.190
LVEF (%), mean (SD) (n = 760) 46.3 (16.0) 47.3 (15.9) 46.1 (16.0) 0.525
DCMP, dilated cardiomyopathy; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass graft; LVEF, left ventricular ejection fraction.
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tion. In addition, EMS patients more often had chronic cardiac illnesses,
whichmost likely improve their awareness of warning signs and symp-
toms. Finally, patient's subjective judgment of symptom severity varies
and alters the threshold for seeking medical attention.
The most frequently assessed urgency category by the emergency-
dispatching centre was category C, in which the recommended re-
sponse time (b30 min) was well achieved. The average EMS response
time in our study was clearly shorter compared to a previous study, in
which the median response time was over three-fold [12]. An explana-
tion for the short response time might be the relatively short distances
and light traffic in the Helsinki metropolitan area. However, in only
slightly more than half of the most urgent EMS calls, the response
timeswerewithin 8min. It has been reported that only when the trans-
portation time exceeds 45min the risk of in-hospitalmortality increases
significantly [12]. In our study the transportation time was clearly
shorter, and in line with previous data in the literature [12–14].
The present study reveals that in this large urban area, the adminis-
tration of prehospital treatment is actually rare. Prehospital medication
was administered to only one-third of EMS patients. This could be ex-
plained with the rather short transportation times and distances to
the hospital in the Helsinki metropolitan area. It has been pointed out
that it might be challenging for paramedics to diagnose AHF [15,16].
Consequently, patient's earlier diagnoses might have a major role in
guiding the prehospital treatment. Still, in the present study de novo pa-
tients received pre-hospital medication more often compared to CHF
patients. One explanation might be that due to the uncertain cause of
the presenting symptoms paramedics were more prone to give
symptom-based medication to de novo patients.
The most frequently administered medications were intravenous
morphine and nitrate spray, which is not surprising as dyspnoea and
chest pain were among the main complaints. Still, only one-fifth of
EMS patients received these twomedications. The administration of in-
travenous morphine has been reported to be even scarcer, only 6% re-
ceiving it [17,18]. In addition, guidelines recommend to use morphine
in severe AHF, accompanied by anxiety and dyspnoea [2]. PatientsTable 2
Urgency categories in emergency medical services.
Urgency category All, n = 100 Categor
Response time from call to site 0:19 (0:18) 0:08 (0
Time spent on site 0:28 (0:16) 0:35 (0
Transportation time 0:19 (0:30) 0:20 (0
Total time from call to hospital presentation 1:14 (1:02) 1:04 (0
Times are expressed in hours:minutes, mean (SD). The designated response times were eightmost likely to benefit frommedical therapy are thosewith hypertension
and/or significant hypoxemia [17,19]. The frequent administrations of
nitrate spray could be explained with the high prevalence of coronary
artery disease. Nitrate infusion was administered to less than one-
tenth of the patients. Intravenous beta-blocker was also administered
to only a few patients.
AHF patients are known to have airway constriction in their small
airways, i.e. cardiac asthma. In theory that justifies the use of inhaled
bronchodilators as first aid though data on this topic is conflicting
[20–22]. Anyhow, in our study less than one tenth of patients received
bronchodilator. On the other hand, it has been reported that supple-
mentary oxygen, semi-recumbent positioning and monitoring of vital
signs on their own could be sufficient prehospital treatment [4,17].
Moreover, some data have shown that the addition of pharmacological
treatment to CPAP in a prehospital setting results in no measurable im-
provement among AHF patients compared with CPAP alone [5].
It is recommended to use CPAP when there is a clinical suspicion of
pulmonary oedema. A previous study demonstrated that prehospital
CPAP treatment has a positive effect on RR, HR, SpO2, and SBP in patients
suffering from pulmonary oedema [6]. However, none of our patients
received CPAP treatment though one third of the patients were hypox-
emic. The use of CPAPwas also reported to be rare in a previous study, in
which only 1% of patients received the treatment [23].
Not surprisingly, EMS patients' status was initially less stable than
the non-EMS patients'. No significant improvement was observed in
EMS patients' vital signs, expect from HR, from site to the ED presenta-
tion. In contrast, a previous study reported an improvement in patients'
vital signs (SBP, mean arterial pressure, HR, RR, and SpO2) after
prehospital treatment [17]. However, these patients were initially less
stable than those in our study. This particular study suggested that the
level of improvement in vital signs is dependent on the initial values.
Thus, themore stable initial status alongwith infrequent administration
of prehospital medication could explain the smaller improvement in
vital signs in our study. On presentation to the ED no significant differ-
ences were observed in vital signs between EMS and non-EMS patients.
However, dry and cold profile was more common in EMS compared toies A and B, n = 33 Category C, n = 46 Category D, n = 20
:03) 0:17 (0:10) 0:40 (0:26)
:09) 0:26 (0:18) 0:21 (0:15)
:37) 0:16 (0:25) 0:25 (0:30)
:32) 1:14 (1:18) 1:37 (1:02)
minutes in urgency categories A and B, 30 min in category C, and 120 min in category D.
Table 3
Pre-hospital and admission vital signs and blood pressure classes on admission.
1. First pre-hospital values of the EMS
group
2. ED admission values of the EMS
group
3. ED admission values of the non-EMS
group
SBP (mm Hg), mean (SD) 139.0 (32.1) 140.6 (27.0) 139.6 (29.7)
Heart rate (bpm), mean (SD) 89.2 (22.5) 84.5 (19.0) [1] 83.7 (21.5) [2]
Respiratory rate (/min), n = 718, mean (SD) 22.9 (6.6) 22.3 (6.7) 22.5 (7.6)
SpO2 (%), mean (SD) 90.3 (8.6) 91.8 (8.5) 92.9 (6.6) [3]
SpO2 b 90%, n (%) 33 (33.0) 24 (24.0) 147 (19.2)
SBP b 100 mm Hg, n (%) 6 (6.5) 6 (6.0) 39 (5.1)
SBP 100–119 mm Hg, n (%) 17 (18.3) 17 (17.0) 145 (18.9)
SBP 120–160 mm Hg, n (%) 46 (49.5) 53 (53.0) 432 (56.4)
SBP N 160 mm Hg, n (%) 24 (25.8) 24 (24.0) 150 (19.6)
SBP, systolic blood pressure. Statistical comparisons were carried out between groups one and two, two and three, and one and three. [1] p = 0.024 for comparison between groups one
and two, [2] p= 0.018 for comparison between groups one and three, [3] p= 0.006 for comparison between groups one and three. The initial SBP wasmissing from seven EMS patients.
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or mildly hypertensive, while minority of patients was regarded as hy-
potensive. This finding is in line with previous data [3,24]. In addition
no differencewas observed in themost recently reported LVEF between
EMS and non-EMS patients.
Despite the fact that EMS patients tended to have more comorbidi-
ties, no difference was seen in the in-hospital mortality between EMS
and non-EMS patients. Neither did further analysis with propensity
score change the result. The finding that EMS and non-EMS patients
were almost equally stable on presentation to the ED and that no differ-
ence was seen in in-hospital mortality importantly demonstrates that
all AHF patients should receive equally careful observation on presenta-
tion to the ED.5. Limitations
Thiswas a retrospective study. Aswe limited data to basic vital signs,
we can assume that the results are reliable. Due to the fact that only 100
out of our total 873 AHF patients used EMS, our EMS cohort was rela-
tively small. We also had missing data for some analysed parameters,
especially the RR, which further restricted the number of values. Yet, it
is a common finding that RR is the least systematically recorded vital
sign [25,26]. The use of oxygen is not recorded in EMS and could not
therefore be analysed.
The patients were initially relatively stable and therefore outcomes
might have been different in more unstable patients. Patients passing
ED e.g. directly to coronary care unit (CCU) were not included in the
study. However, this did not exclude every acute coronary syndrome
patient from our study population.
The data represents local policies andmay not be universally gen-
eralizable. The pattern of prehospital medication administration
may differ from that in other countries. Our EMS units are not
equipped with intravenous furosemide, and only the most advanced
EMS units, ALS and MICU, have the possibility for CPAP use and
bronchodilators.6. Conclusion
EMS use in AHF patients is predicted by clinical condition and earlier
history of HF, but appears to be scarce. Few medications are adminis-
tered in the prehospital setting, with nitrate spray and intravenousmor-
phine being the most frequently administered ones. No differences are
observed between non-EMS and EMS patients' vital signs on presenta-
tion to ED, LOS or in-hospital mortality. This underscores the need for
equal attention to any AHF patient independent of the arrival mode.
Moreover, as the clinical scenario of worsening CHF differs from cardio-
vascular emergencies like acute myocardial infarction or stroke with
immediate onset, specific concepts of prehospital care have to be
assessed in further studies.Funding
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